Melissa Toyos
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (NCT01847638) | Melissa Toyos | 2013-04-01 |
Track Melissa Toyos automatically
Every clearance here is in the API, with alerts when new ones post.